Coronavirus | Eli Lilly India combination gets nod for emergency use
Updated:
Updated:
It could be used for treatment of mild to moderate COVID-19
Share Article
AAA
Eli Lilly and Company India on Tuesday said it has received permission for emergency use of its antibody drugs combination used for treatment of mild to moderate COVID-19.
| Photo Credit:
REUTERS
It could be used for treatment of mild to moderate COVID-19
Eli Lilly and Company India on Tuesday said it has received permission for emergency use of its antibody drugs combination used for treatment of mild to moderate COVID-19.
The company has received permission for restricted emergency use of its monoclonal antibody drugs, bamlanivimab 700 mg and etesevimab 1400 mg, used together for the treatment, it said in a statement.